Resources

Word document

1. References
2. Bibliography
3. Additional End-Of-Life Resources

References

1. Sidedall, P. J., & Cousins, M. J. (1997). Spine update spinal pain mechanisms. Spine, 22, 98-104.
2. Dickenson, A. H. (1995). Central acute pain mechanisms. Annals of Medicine, 27, 223-227.
3. Weissman, G. (1991). The actions of NSAIDs. Hospital Practice, 26, 60-76.
4. Stambaugh, J., & Drew, J. (1988). A double-blind parallel evaluation of the efficacy of a single dose of ketoprofen in cancer pain. Journal of Clinical Pharmacology, 28, S39.
5. Cashman, J. N. (1996). The mechanisms of action of NSAIDs in analgesia. Drugs, 52(suppl. 5), 13-23.
6. Willis, W. D., & Westlund, K. N. (1997). Neuroanatomy of the pain system and of the pathways that modulate pain. Journal of Clinical Neurophysiology, 14, 2-31.
7. Stambaugh, J. E., & Lane, C. (1983). Analgesic efficacy and pharmacokinetic evaluation of meperidine and hydroxyzine, alone and in combination. Cancer Investigations, 1, 111-117.
8. Gonzales, R., Goldyne, M. E., Taiwo, Y. O., & Levine, J. D. (1989). Production of hyperalgesic prostaglandins by sympathetic postganglionic neurons. Journal of Neurochemistry, 53(5), 1595-1608.
9. Sato, J., & Perl, E. R. (1991). Adrenergic excitation of cutaneous pain receptors induced by peripheral nerve injury. Science, 251, 1608-1610.
10. American Pain Society. (1998). Principles of analgesic use in the treatment of acute pain and chronic cancer pain: A concise guide to medical practice ( 4th ed. ed.). Skokie, IL: American Pain Society.
11. U.S. Department of Health and Human Services. (1992). Clinical practice guideline. Acute pain management: Operative or medical procedures and trauma. Rockville, MD: Agency for Health Care Policy and Research.
12. U.S. Department of Health and Human Services. (1994). Clinical practice guideline. Management of cancer pain. Rockville, MD: Agency for Health Care Policy and Research.
13. World Health Organization. (1996). Cancer pain relief ( 2nd ed. ed.). Geneva: World Health Organization.
14. Wilkie, D., Lovejoy, N., Dodd, M., & Tesler, M. (1988). Cancer pain control behaviors: description and correlation with pain intensity. Oncol Nurs Forum, 15(6), 723-731.
15. Wilkie, D. J., Keefe, F. J., Dodd, M. J., & Copp, L. A. (1992). Behavior of patients with lung cancer: description and associations with oncologic and pain variables. Pain, 51(2), 231-240.
16. Cousins, M. (1994). Acute and postoperative pain. In M. R. Wall PD (Ed.), Textbook of pain (3rd ed ed., pp. 357-385). New York: Churchill Livingstone.
17. Garoutte, B. (1981). Survey of functional neuroanatomy. Greenbrae, CA: Jones Medical Publications.
18. Woolf, C. J., & Wiesenfield-Hallin, Z. (1985). The systemic administration of local anaesthetics produce a selective depression of C-afferent fiber evoked activity in the spinal cord. Pain, 23, 361-374.
19. Wilkie, D. J., Vivenzo, K., & Puntillo, K. (1991). Point: registered nurses should administer and monitor spinal analgesia within the state-defined scope of practice--the California perspective. Nurse Anesth, 2(1), 6-9.
20. Fields, H. L. (1987). Pain. New York: McGraw-Hill.
21. Coderre, T. J., Katz, J., Vaccarino, A. L., & Melzack, R. (1993). Contribution of central neuroplasticity to pathological pain: Review of clinical and experimental evidence. Pain, 52(3), 259-285.
22. Yaksh, T. L. (1991). The spinal pharmacology of anomalous pain processing. In K. L. Casey (Ed.), Pain and central nervous system disease: The central pain syndromes (pp. 243-256). New York: Raven Press.
23. Casey, L., Minoshima, S., Morrow, T. J., & Koeppe, R. A. (1996). Comparison of human cerebral activation pattern during cutaneous warmth, heat pain, and deep cold pain. Journal of Neurophysiology, 76, 571-581.
24. Jones, A. K. P. (1997). Pain, its perception, and pain imaging. IASP Newsletter, 3, 3-5.
25. Sweet, W. H., Poletti, C. E., & Gybels, J. M. (1994). Operations in the brainstem and spinal canal, with and appendix on the relationship of open to percutaneous cordotomy. In R. M. P.D. Wall (Ed.), Textbook of pain (3rd ed ed., pp. 1113-1135). New York: Churchill Livingstone.
26. Rosomoff, H. L., Papo, I., & Loeser, J. (1990). Neurosurgical operations on the spinal cord. In J. J. Bonica (Ed.), The management of pain (v. II ed., pp. 2067-2081). Philadelphia: Lea & Febiger.
27. Guilbaud, G., Besson, J. M., Oliveras, J. L., & Liebeskind, J. C. (1973). Suppression by LSD of the inhibitory effect exerted by dorsal raphe stimulation in certain spinal cord interneurons in the cat. Brain Research, 61, 417-422.
28. Basbaum, A. I., Clanton, C. H., & Fields, H. L. (1976). Opiate and stimulus-produced analgesia: Functional anatomy of a medullospinal pathway., 73(12), 4685-4588.
29. Fields, H. L., & Heinricher, M. M. (1985). Anatomy and physiology of a nociceptive modulatory system. Philosophical Transactions of the Royal Society of London Series B: Biological Sciences, 308(1136), 361-374.
30. Fields, H. L., & Basbaum, A. L. (1994). Central nervous system mechanisms of pain modulation. In M. R. Wall PD (Ed.), Textbook of pain (3rd ed. ed., pp. 243-257). New York: Churchill Livingstone.
31. Herz, A. (1996). Peripheral opioid analgesia - Facts and mechanisms. Progress in Brain Research, 110, 95-104.
32. Max, M. B., Zeigler, D., Shoaf, S. E., Craig, B. E., Benjamin, J., Li, S. H., Buzzanell, C., Perez, M., & Ghosh, B. C. (1992). Effects of a single dose of desipramine on postoperative morphine analgesia. Journal of Pain and Symptom Management, 7, 454-462.
33. McQuay, H., Carroll, D., Jadad, A. R., Wiffen, P., & Moore, A. (1995). Anticonvulsant drugs for management of pain: A systemic review. British Medical Journal, 311, 1047-1052.
34. Gee, N. S., Brown, J. P., Dissanayake, V. U., Offord, J., Thurlow, R., & Woodruff, G. N. (1996). The novel anticonvulsant drug, gabapentin (neurontin), binds to the alpha2delta subunit of a calcium channel. Journal of Biological Chemistry, 271(10), 5768-5776.
35. Levine, J. D., Gordon, N. C., & Fields, H. L. (1978). The mechanism of placebo analgesia. Lancet, 2, 654-657.
36. LeBars, D., Dickenson, A. H., & Besson, J. M. (1979). Diffuse noxious inhibitory controls DNIC. Effects on dorsal horn convergent neurons in the rat. Pain, 6, 283-304.
37. Melzack, R., & Wall, P. (1965). Pain mechanisms: A new theory. Science, 150, 971-979.

Bibliography

1. Besson, JM. (1999). The neurobiology of pain. Lancet, 353(9164), 1610-5.
2. Bonica, JJ. (Ed.). (1990). Management of pain (2nd Ed.). Philadelphia: Lea & Febiger.
3. Carstens, E. (1996). Quantitative experimental assessment of pain and hyperalgesia in animals and underlying neural mechanisms. Prog. Brain Res., 110, 17-31.
4. Casey, K.L. (1991). Pain and central nervous system disease: the central pain syndromes. New York: Raven Press.
5. Casey, K.L., Minoshima, S., Morrow, T.J., & Koeppe, R.A. (1996). Comparison of human cerebral activation pattern during cutaneous warmth, heat pain, and deep cold pain. J. Neurophysiol., 76(1), 571-81.
6. Cervero, F. (1995). Visceral pain: mechanisms of peripheral and central sensitization. Ann. Med., 27(2), 235-9.
7. Cervero, F. (1996). Spinal cord mechanisms of hyperalgesia and allodynia: role of peripheral input from nociceptors. Prog. Brain Res., 113, 413-22.
8. Cervero, F., & Laird, J.M. (1996). From acute to chronic pain: mechanisms and hypotheses. Prog. Brain Res., 110, 3-15.
9. Chabal, C., Russell, L.C., & Burchiel, K.J. (1989). The effect of intravenous lidocaine, tocaininde, and mexiletine on spontaneously active fibers originating in rat sciatic neuromas. Pain, 38, 333-338.
10. Coderre, T.J., Katz, J., Vaccarino, A.L., & Melzack, R. (1993). Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain, 52(3), 259-85.
11. Desmees J, Gascon, MP, Dayer P, & Magistris M. (1991). Impact of environmental and genetic factors on codeine analgesia. European Journal of Clinical Pharmacology, 41, 23-26.
12. Dickenson, A.H. (1995). Central acute pain mechanisms. Ann. Med., 27(2), 223-7.
13. Dray, A. (1996). Neurogenic mechanisms and neuropeptides in chronic pain. Prog. Brain Res., 110, 85-94.
14. Fields, H.L., & Liebeskind, J.C. (Eds.). (1994). Pharmacological Approaches to the Treatment of Chronic Pain: New Concepts and Critical Issues. Seattle: International Association for the Study of Pain (IASP) Press.
15. Good, M., (1999). Acute pain. Annual Review of Nursing Research, 17, 107-32.
16. Herz, A. (1996). Peripheral opioid analgesia--facts and mechanisms. Prog. Brain Res., 110, 95-104.
17. Hill, A. (1999). Phantom limb pain: a review of the literature on attributes and potential mechanisms. Journal of Pain & Symptom Management, 17(2), 125-42.
18. Konttinen, Y.T., Kemppinen, P., Segerberg, M., Hukkanen, M., Rees, R., Santavirta, S., Sorsa, T., Pertovaara, A., & Polak, J.M. (1994). Peripheral and spinal neural mechanisms in arthritis, with particular reference to treatment of inflammation and pain. Arthritis. Rheu., 37(7), 965-82.
19. Mao, J., Price, D.D., & Meyer, D.J. (1995). Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain, 62(3), 259-74.
20. Markenson, J.A. (1996). Mechanisms of chronic pain. Am. J. Med., 101(1A), 6S-18S.
21. Mayer, DJ, et al. (1999). Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions. Proc Natl Acad Sci U S A, 96(14), 7731-6.
22. McMahon, S.B. (1996). NGF as a mediator of inflammatory pain. Philos. Trans. R. Soc. Lond. B. Biol. Sci., 351(1338), 431-40.
23. Melzack, R., & Wall, P.D. (1996). Pain mechanisms: a new theory. Pain Forum, 5(1), 3-11 (reprinted from Science, 1965)
24. Melzack, R. (1997). Phantom limb pain: concept of a central biasing mechanism. Clin. Neurosurg, 18, 188-207.
25. Mercadante, S. (1997). Malignant bone pain: pathophysiology and treatment. Pain, 69(1-2),1-18.
26. Merskey, H. & Bogduk, N. (1994). Classification of chronic pain: Descriptions of chronic pain syndromes and definitions of pain terms. Seattle: IASP Press.
27. Mogil, J.S. (1999). The genetic mediation of individual differences in sensitivity to pain and its inhibition. Proc. Natl. Acad. Sci., 96, 7744-7751.
28. Olivar, T, et al. (1999). Differential effects of N-methyl-D-aspartate blockade on nociceptive somatic and visceral reflexes. Pain, 79(1), 67-73.
29. Ollat, H., & Cesaro, P. (1995). Pharmacology of neuropathic pain. Clin. Neuropharmacol., 18(5), 391-404.
30. Page, G.G. (1996). The medical necessity of adequate pain management. Pain Forum, 5(4), 227-233.
31. Page, G.G., Ben-Eliyahu, S., Yirmiya, R., et al (1993). Morphine attenuates surgery-induced enhancement of metastatic colonization in rats. Pain, 54, 21-28.
32. Payne, R (1997). Mechanisms and management of bone pain. Cancer, 80(8 Suppl), 1608-13.
33. Perl, E.R. (1996). Cutaneous polymodal receptors: characteristics and plasticity. Prog. Brain Res., 113, 21-37.
34. Portenoy, R.K., Foley, K.M., Stulman, J., Khan, E., Adelhardt, J., Layman, M., Cerbone, D.F., & Inturrisi, C.E. (1991). Plasma morphine and morphine-6-glucuronide during chronic morphine therapy for cancer pain: Plasma profiles, steady-state concentrations, and the consequences of renal failure. Pain, 47, 13-19.
35. Robison, J. M., Wilkie, D. J., & Campbell, B. (1995). Sublingual and oral morphine administration: Review and new findings. Nursing Clinics of North America, 30, 725-743.
36. Sato J., & Perl E. R. (1991). Adrenergic excitation of cutaneous pain receptors induced by peripheral nerve injury. Science, 251, 1608-1610.
37. Sessle, B.J., & Hu, J.W. (1991). Mechanisms of pain arising from articular tissues. Can. J. Physiol. Pharmacol. 69(5), 617-26.
38. Siddall, P.J., & Cousins, M.J. (1995). Pain mechanisms and management: an update. Clin. Exp. Pharmacol. Physiol., 22(10), 679-88.
39. Siddall, P.J., & Cousins, M.J. (1997). Spinal pain mechanisms. Spine, 22(1), 98-104.
40. Simone, D.A. (1992). Neural mechanisms of hyperalgesia. Curr. Opin. Neurobiol., 2(4), 479-83.
41. Sindrup SH, Poulsen L, Brosen K, Arendt-Nielsen L, & Gram LF. (1993). Are poor metabolizers of sparteine/debrisoquine less pain tolerant than extensive metabolisers? Pain, 53, 335-349.
42. Stamford, J.A. (1995). Descending control of pain. Br. J. Anaesth., 75(2), 217-27.
43. Tanner, KD, et al. (1998). Nociceptor hyper-responsiveness during vincristine-induced painful peripheral neuropathy in the rat. Journal of Neuroscience, 18(16),6480-91.
44. Treede, R.D., Meyer, R.A., Raja, S.N., & Campbell, J.N. (1992). Peripheral and central mechanisms of cutaneous hyperalgesia. Prog. Neurobiol., 38(4), 397-421.
45. Uhl, G.R., Sora, I., & Wang, Z. (1999). The mu opiate receptor as a candidate gene for pain: Polymorphisms, variations in expression, nociception, and opiate responses. Proc. Natl. Acad. Sci., 96, 7752-7755.
46. Unruh, A.M. (1996). Gender variations in clinical pain experience. Pain, 65(2-3), 123-67.
47. Walker, J.S. (1995). NSAID: An update on their analgesic effects. Clinical and Experimental Pharmacology and Physiology, 22, 855-860.
48. Wall, P. D., & Melzack, R. (Eds.). (1994). Textbook of pain (3rd Ed). Edinburgh: Churchill Livingstone.
49. Wall. P. D. (1996). Comments after 30 years of the Gate Control Theory. Pain Forum, 5(1), 12-22.
50. Weissman G. (1991). The actions of NSAIDs. Hospital Practice, 26, 60-76.
51. White, DM, et al.(1998). Effect of subcutaneous administration of calcium channel blockers on nerve injury-induced hyperalgesia. Brain Research, 801(1-2),50-8.
52. Wilkie, D.J. (1995). Neural mechanisms of pain: Foundation for cancer pain assessment and management. In D.B. McGuire, C.H. Yarbro, & B.R. Ferrell (Eds.). Cancer pain management (2nd Ed) (pp. 61-87). Jones and Bartlett: Boston.
53. Wilkie, D.J. (1996). Pain perception and comfort. In R. Craven & C. Hirnle (Eds.), Fundamentals of nursing: Human health and function (2nd ed.) (pp. 1300-1336). Lippincott: New York.
54. Wilkie, D.J., & Boss, B.J. (1999). Nursing assessment and role in management: Pain. In S.L. Lewis, I.C. Hawkins, & M.M. Heitkemper (Eds.), Medical-surgical nursing: Assessment and management of clinical problems (5th ed) (pp. 124-154). Mosby: St. Louis.
55. Willis, W.D., & Westlund, K.N. (1997). Neuroanatomy of the pain system and of the pathways that modulate pain. J. Clin. Neurophysiol., 14(1), 2-31.
56. Willis, W.D., Sluka, K.A., Rees, H., & Westlund, K.N. (1996). Cooperative mechanisms of neurotransmitter action in central nervous sensitization. Prog. Brain Res., 110, 151-66.
57. Woolf, CJ, et al. (1999). Transcriptional and posttranslational plasticity and the generation of inflammatory pain. Proc Natl Acad Sci U S A, 96(14), 7723-30.